HIV medications; prohibit health plans and Medicaid from subjecting to protocols that restrict dispensing of.

HB 144 prohibits health insurance plans, Medicaid, and pharmacy benefit managers from requiring prior authorization, step therapy, or other protocols that delay or restrict access to FDA-approved HIV/AIDS medications (antiretroviral drugs). It mandates that insurers cover at least one therapeutically equivalent version of these medications without prior approval, ensuring patients can access treatment without unnecessary barriers. The bill also requires insurers to publicly list HIV medication coverage exceptions on their websites and clarifies override processes for step therapy protocols. The bill died in committee on February 3, 2026, and never became law.